U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899060) titled 'Safety and Efficacy of RashEndZ Wound Aeration Technology' on March 29, 2021.
Brief Summary: The aim of this study is to determine the safety and efficacy of RashEndZ therapeutic liner technology and Dynamic Oxygen Skin Therapy in improving symptoms and expediting healing of IAD and DU in adult patients.
Study Start Date: June 21, 2016
Study Type: INTERVENTIONAL
Condition:
Incontinence-associated Dermatitis
Decubitus Ulcer
Intervention:
DEVICE: Dynamic Oxygen Skin Therapy (DOST)
Continuous application of respiratory oxygen, at 3-4 L/min, to each wound using the patented RashEndZ Wound Aeration Technology
OTHER: Standard Woun...